COMMUNIQUÉS West-GlobeNewswire

Phase IIb Study Results of InnoCare’s Orelabrutinib in Patients with SLE Presented at 2026 EULAR
05/06/2026
BEIJING, June 05, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that study results [...]
Native Life Appoints FIFA Brand Designer Jody Ure to Lead Creative Strategy and Support National Expansion
05/06/2026
Miami, Florida, June 04, 2026 (GLOBE NEWSWIRE) -- Native Life, an emerging life and health insurance company operating across all 50 states, announced the appointment of globally recognized FIFA brand designer Jody Ure [...]
CooperCompanies Announces Second Quarter 2026 Results
04/06/2026
SAN RAMON, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal second quarter ended April 30, 2026. Second [...]
Orange Plan Management Celebrates 4.9-Star Review Milestone, Reinforcing Its Role as a Leading NDIS Plan Manager in Australia
04/06/2026
Brisbane, QUEENSLAND, June 04, 2026 (GLOBE NEWSWIRE) -- Orange Plan Management , an Australian NDIS plan management provider, announced today that it has achieved a 4.9-star Google rating across more than 50 customer [...]
GILEAD SCIENCES AND LAKEFRONT COMPLETE ACQUISITION OF OURO MEDICINES TO FURTHER EXPAND INFLAMMATION PIPELINE
04/06/2026
Companies will collaborate on the development of gamgertamig, a potential first-in-class and best-in-class T cell engager in autoimmune diseases Foster City, Calif. and Mechelen, Belgium; June 4, 2026, 22.15 CET – [...]
Nyxoah Annonce une Proposition d'Offre d'Actions Ordinaires
04/06/2026
INFORMATIONS PRIVILÉGIÉES INFORMATIONS RÉGLEMENTÉES Nyxoah Annonce une Proposition d'Offre d'Actions Ordinaires Mont-Saint-Guibert, Belgique – 4 juin 2026, 22h02 CET / 16h02 ET – Nyxoah SA (Euronext Brussels/Nasdaq : [...]
Eledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at American Diabetes Association (ADA) 2026 Scientific Sessions
04/06/2026
IRVINE, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that updated results from an investigator-initiated trial being conducted at the University of [...]
Aja Health and Wellness Inc. Announces Agreement for the Sale of Assets of GOeVisit Service
05/06/2026
Not for dissemination in the United States of America VANCOUVER, British Columbia, June 04, 2026 (GLOBE NEWSWIRE) -- Aja Health and Wellness Inc. ("Aja" or the "Company") (TSXV:Aja) announces that its wholly-owned [...]
BIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN. BHD.
04/06/2026
Creation of a next-generation environmental platform: The proposed transaction brings together essential safety and environmental services, with a strategic focus on regulatory-driven industries where compliance, [...]
Lyell Immunopharma to Present Phase 1/2 Safety and Translational Data for Ronde-Cel in Large B-Cell Lymphoma at the European Hematology Association 2026 Congress
04/06/2026
SOUTH SAN FRANCISCO, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell [...]
TOMI Expands European Footprint with New Regulatory Approvals for Binary Ionization Technology
04/06/2026
European Union Market Expansion Advances with Official Authorization in Austria and Italy FREDERICK, Md., June 04, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global leader [...]
Nyxoah Entre dans une Nouvelle Phase de Création de Valeur à Long Terme
04/06/2026
INFORMATIONS PRIVILÉGIÉES INFORMATIONS RÉGLEMENTÉES Nyxoah Entre dans une Nouvelle Phase de Création de Valeur à Long Terme Lancement du processus de transition vers un Chief Executive Officer basé aux États-Unis Cette [...]
Nyxoah Enters New Chapter of Long Term Value Creation
04/06/2026
INSIDE INFORMATION REGULATED INFORMATION Nyxoah Enters New Chapter of Long Term Value Creation Commencement of process to transition to a U.S.-based CEO Transition to support further acceleration of commercial Genio [...]
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04/06/2026
NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on June 1, 2026, the Company [...]
Nyxoah Announces Proposed Offering of Ordinary Shares
04/06/2026
INSIDE INFORMATION REGULATED INFORMATION Nyxoah Announces Proposed Offering of Ordinary Shares Mont-Saint-Guibert, Belgium – June 4, 2026, 10:02 pm CET / 4:02 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah [...]
Cloudbreak Pharma Announces Final Patient Visit for 12-Month Efficacy Endpoint in Phase 3 Study of CBT-001 as a Potential Treatment for Pterygium
04/06/2026
Milestone achievement advances potential first FDA-approved disease-modifying therapy for pterygium, a condition affecting just under one billion people globally, including 15 million people in the U.S. Topline data [...]
Laguna Treatment Center Warns of Concerning Increase in Patients Seeking Help for Kratom Addiction
05/06/2026
ALISO VIEJO, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- Laguna Treatment Center, a leading provider of addiction and co-occurring disorder treatment in Orange County, CA is issuing a warning to Californians and [...]
SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026
04/06/2026
SANTA CLARA, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced [...]
Praxis Precision Medicines to Participate in Goldmans Sachs 47th Annual Global Healthcare Conference
04/06/2026
BOSTON, June 04, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines , Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced it [...]

Pages